Planning and evaluation activities have played a key role in the growth and steady improvement of KUCC. Multiple internal committees including KUCC Leadership Council and Associate Directors Council guide the planning and evaluation process under the leadership of Director Jensen and in coordination with the External Advisory Board (EAB). The EAB serves a critical role in providing external oversight of planning and evaluation of KUCC vision, direction, leadership, research programs, and supporting infrastructure. The EAB was selected by KUCC leadership to match our research programs, shared resources and administrative components. The EAB has made numerous major recommendations such as defining the relationship between the KU Hospital and KUCC, increasing the number of patients on therapeutic trials, suggesting a timeline for the PSO application, suggesting ways to tighten membership criteria, expanding the number of NCI funded investigators, better integrating with the Stowers Institute for Medical Research, integrating clinicians into the Drug Discovery, Delivery and Experimental Therapeutics Program, and improving the KUCC website. KUCC Leadership Council promotes scientific interactions between the basic, translational, and clinical elements of the Center, plans development of the research programs, leverages KUCC resources for maximum benefit, and oversees activities of KUCC programs. The Associate Directors Council evaluates cross-program activities including symposia, seminars and conferences, allocations of pre-and post-doctoral trainee stipends and KUCC pilot research grants, and new research membership applications as well as conducts an annual review of membership. Each year the Associate Directors Council reviews the progress of the research programs, shared resources and administrative functions of KUCC. The KUCC-ADC makes final recommendations to the Director on practically all issues including budget, resource allocation, membership, space, leadership appointments, and strategic direction. The MCA Partners Advisory Board promotes collaboration of key hospitals and research institutions in the areas of research and education and advises the Cancer Center Director on the impact of KUCC in the community.

Public Health Relevance

Planning and evaluation activities have clearly been an essential component of our continued and steady improvement over the last seven years and will continue to play a critical role in the future. KUCC's External Advisory Board and key internal advisory groups have played important roles in this activity and this has resulted in a vigorous and robust process of envisioning our potential, thoughtful reflection, and proactive change management.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA168524-02
Application #
8557675
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
2
Fiscal Year
2013
Total Cost
$17,765
Indirect Cost
Name
University of Kansas
Department
Type
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Grieshober, Laurie; Graw, Stefan; Barnett, Matt J et al. (2018) Methylation-derived Neutrophil-to-Lymphocyte Ratio and Lung Cancer Risk in Heavy Smokers. Cancer Prev Res (Phila) 11:727-734
Crooker, Kyle; Aliani, Rana; Ananth, Megha et al. (2018) A Review of Promising Natural Chemopreventive Agents for Head and Neck Cancer. Cancer Prev Res (Phila) 11:441-450
Gonzalez-Mercado, Velda J; Fridley, Brooke L; Saligan, Leorey N (2018) Sestrin family of genes and their role in cancer-related fatigue. Support Care Cancer 26:2071-2074
Rebbeck, Timothy R (see original citation for additional authors) (2018) Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Hum Mutat 39:593-620
Roy, Anuradha (2018) Early Probe and Drug Discovery in Academia: A Minireview. High Throughput 7:
Lea, Wendy A; Parnell, Stephen C; Wallace, Darren P et al. (2018) Human-Specific Abnormal Alternative Splicing of Wild-Type PKD1 Induces Premature Termination of Polycystin-1. J Am Soc Nephrol 29:2482-2492
Hirst, Jeff; Pathak, Harsh B; Hyter, Stephen et al. (2018) Licofelone Enhances the Efficacy of Paclitaxel in Ovarian Cancer by Reversing Drug Resistance and Tumor Stem-like Properties. Cancer Res 78:4370-4385
Trinca, Gloria M; Goodman, Merit L; Papachristou, Evangelia K et al. (2018) O-GlcNAc-Dependent Regulation of Progesterone Receptor Function in Breast Cancer. Horm Cancer 9:12-21
Subramaniam, Dharmalingam; Kaushik, Gaurav; Dandawate, Prasad et al. (2018) Targeting Cancer Stem Cells for Chemoprevention of Pancreatic Cancer. Curr Med Chem 25:2585-2594
Beadnell, Thomas C; Scheid, Adam D; Vivian, Carolyn J et al. (2018) Roles of the mitochondrial genetics in cancer metastasis: not to be ignored any longer. Cancer Metastasis Rev :

Showing the most recent 10 out of 177 publications